Can you give us an update on the vaccine for children? When do you envisage this will become available? – Anna Chircop The US Food and Drug Administration (FDA) and the US Centres for Disease Control (CDC) have recently authorised the use of the Pfizer-BioNTech vaccine for children from 12 years up. This means the FDA and the CDC determined that clinical trials show this vaccine is safe and effective for children in this age range. The European Medicines Agency is currently evaluating data from these trials with a view to approving the use of Pfizer-BioNTech vaccine for use in children from 12 years up within EU member states. Once approval is given, we shall include this age group in the vaccination strategy for Malta. Pfizer-BioNTech vaccine is already authorised by EMA for anyone over 16 and is currently being offered to those who are registering with the national vaccination programme. Current safety and efficacy testing of other COVID vaccines for children aged two and up may lead to authorisation of one or more of the COVID-19 vaccines for younger children in the months ahead. Do you think schools will have to follow this year’s mitigation measures in the upcoming...